| Dr Monica Ata, MONICA ATA DO | |
|
5944 West Parker Rd, Suite 400, Plano, TX 75093 | |
| (972) 980-0500 | |
| Not Available |
| Full Name | Dr Monica Ata |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 5944 West Parker Rd, Plano, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023305851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | P8843 (Texas) | Primary |
| Entity Name | Arcadia Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568800266 PECOS PAC ID: 8325280829 Enrollment ID: O20130813000631 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Reliance Anesthesia Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467865600 PECOS PAC ID: 6002033982 Enrollment ID: O20140818000793 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Arcadia Anesthesia Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063867463 PECOS PAC ID: 8022309772 Enrollment ID: O20160628000139 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Vertex Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487106175 PECOS PAC ID: 1052692324 Enrollment ID: O20161228000298 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Texas Anesthesia Partners, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144673468 PECOS PAC ID: 3870879828 Enrollment ID: O20170406000406 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Sol Texas Anesthesia Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558812149 PECOS PAC ID: 6507134376 Enrollment ID: O20170620001342 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Texas Consultants In Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912412750 PECOS PAC ID: 5496014920 Enrollment ID: O20180109000788 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20180905000794 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Dallas Anesthesia Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316596919 PECOS PAC ID: 2961823281 Enrollment ID: O20200522000019 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Texas Anesthesia Service Consultants |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528631058 PECOS PAC ID: 2567866767 Enrollment ID: O20210810003732 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Entity Name | Pamica |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801547096 PECOS PAC ID: 5395131858 Enrollment ID: O20220408002040 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Monica Ata, MONICA ATA DO Po Box 702097, Dallas, TX 75370-2097 Ph: () - | Dr Monica Ata, MONICA ATA DO 5944 West Parker Rd, Suite 400, Plano, TX 75093 Ph: (972) 980-0500 |
News Archive
The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).
AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.
Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.
From 2000 to 2015, more than a half million people died from drug overdoses. Many of these individuals tried to recover from their addiction by seeking treatment at specialty addiction programs.
› Verified 5 days ago
Dr. Paul S Dereska, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3308 Preston Rd, Ste. 350-283, Plano, TX 75093 Phone: 214-471-5975 | |
Dr. Sameer Ali Syed, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3151 W 15th St, Plano, TX 75075 Phone: 214-817-4225 Fax: 972-674-2788 | |
Tejas Vasant Ozarkar, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5425 W. Spring Creek Parkway, Suite 100, Plano, TX 75024 Phone: 972-596-1059 Fax: 972-612-5410 | |
Ola Yinka, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6009 W Parker Rd # 149-261, Plano, TX 75093 Phone: 214-274-9314 | |
Dr. Matt Ted Gubert, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Chisholm Pl Ste 406, Plano, TX 75075 Phone: 972-588-4541 Fax: 469-304-0139 | |
Dr. Brad Richard Davis, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Plano Pkwy, Suite 100, Plano, TX 75074 Phone: 972-422-5941 Fax: 972-881-4390 |